Itraconazole for 'red face' during treatment with dupilumab

F. de Beer; I. Haeck; D. Bakker; L. Ariëns; J. van der Schaft; M. van Dijk; M. de Bruin-Weller

Itraconazole for 'red face' during treatment with dupilumab

F. de Beer, I. Haeck, D. Bakker, L. Ariëns, J. van der Schaft, M. van Dijk, M. de Bruin-Weller

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

We present three patients who developed pronounced redness and scaling in the face, head and neck during treatment with dupilumab indicated for atopic dermatitis (AD). Clinically, these patients suffered from head-neck dermatitis, which is a subtype of AD. Histopathological results showed a remarkable neutrophilic dermatosis with an eczematous background and no characteristics of rosacea. We found an elevated serum level of specific IgE for Malassezia. Treatment with oral itraconazole showed a good clinical response. © 2019, Stichting Beheer Tijdschriften Dermatologie. All right reserved.

Original language	English
Pages (from-to)	35-37
Number of pages	3
Journal	Nederlands Tijdschrift voor Dermatologie en Venereologie
Volume	29
Issue number	4
Publication status	Published - 2019

Access to Document

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85076590806&partnerID=40&md5=cb4506a247fc55ae37f1a9d7aada598a

Cite this

@article{5b6141598d9c4f27a35ad497ffd46068,

title = "Itraconazole for 'red face' during treatment with dupilumab",

abstract = "We present three patients who developed pronounced redness and scaling in the face, head and neck during treatment with dupilumab indicated for atopic dermatitis (AD). Clinically, these patients suffered from head-neck dermatitis, which is a subtype of AD. Histopathological results showed a remarkable neutrophilic dermatosis with an eczematous background and no characteristics of rosacea. We found an elevated serum level of specific IgE for Malassezia. Treatment with oral itraconazole showed a good clinical response. {\textcopyright} 2019, Stichting Beheer Tijdschriften Dermatologie. All right reserved.",

author = "{de Beer}, F. and I. Haeck and D. Bakker and L. Ari{\"e}ns and {van der Schaft}, J. and {van Dijk}, M. and {de Bruin-Weller}, M.",

note = "Export Date: 25 March 2021",

year = "2019",

language = "English",

volume = "29",

pages = "35--37",

journal = "Nederlands Tijdschrift voor Dermatologie en Venereologie",

issn = "0925-8604",

publisher = "DCHG Partners in Mediscne Communicatie",

number = "4",

}

TY - JOUR

T1 - Itraconazole for 'red face' during treatment with dupilumab

AU - de Beer, F.

AU - Haeck, I.

AU - Bakker, D.

AU - Ariëns, L.

AU - van der Schaft, J.

AU - van Dijk, M.

AU - de Bruin-Weller, M.

N1 - Export Date: 25 March 2021

PY - 2019

Y1 - 2019

N2 - We present three patients who developed pronounced redness and scaling in the face, head and neck during treatment with dupilumab indicated for atopic dermatitis (AD). Clinically, these patients suffered from head-neck dermatitis, which is a subtype of AD. Histopathological results showed a remarkable neutrophilic dermatosis with an eczematous background and no characteristics of rosacea. We found an elevated serum level of specific IgE for Malassezia. Treatment with oral itraconazole showed a good clinical response. © 2019, Stichting Beheer Tijdschriften Dermatologie. All right reserved.

AB - We present three patients who developed pronounced redness and scaling in the face, head and neck during treatment with dupilumab indicated for atopic dermatitis (AD). Clinically, these patients suffered from head-neck dermatitis, which is a subtype of AD. Histopathological results showed a remarkable neutrophilic dermatosis with an eczematous background and no characteristics of rosacea. We found an elevated serum level of specific IgE for Malassezia. Treatment with oral itraconazole showed a good clinical response. © 2019, Stichting Beheer Tijdschriften Dermatologie. All right reserved.

M3 - Article

SN - 0925-8604

VL - 29

SP - 35

EP - 37

JO - Nederlands Tijdschrift voor Dermatologie en Venereologie

JF - Nederlands Tijdschrift voor Dermatologie en Venereologie

IS - 4

ER -

Itraconazole for 'red face' during treatment with dupilumab

Abstract

Access to Document

Fingerprint

Cite this